Medicamen Biotech Share Price
263.50+4.10 (+1.58%)
-24.83% past 1 Year
News
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.97 Crores, in the March 2026 quarter
Equity
MEDICAMEQ
Medicamen Biotech informs about board meeting
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.59 Crores, in the December 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech Q2 FY26 net profit dips marginally, revenue and EBITDA decline YoY.
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.21 Crores, in the September 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 1.64 Crores, in the June 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech gets USFDA’s approval for Bortezomib for injection
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.41 Crores, in the March 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech signs contract for CDMO with XGX pharma
Equity
MEDICAMEQ
Medicamen Biotech informs about closure of trading window
Equity
MEDICAMEQ
Medicamen Biotech informs about disclosure
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ